Testosterone: prostate villain to ally

This article explores the evolution of testosterone's role in prostate cancer, from being considered a villain to a potential ally. Historically, testosterone was believed to fuel prostate cancer, leading to the widespread use of androgen deprivation therapy. However, recent studies have shown that testosterone therapy does not increase the risk of prostate cancer in men with low testosterone levels. In fact, properly monitored testosterone therapy may even lower cancer rates. For men with active prostate cancer, lowering testosterone remains an effective treatment. The article highlights the complexity of testosterone's effects on prostate cells and the potential for testosterone to be used as a treatment in carefully chosen patients.